Renoprotective effects and safety of sodium-glucose cotransporter 2 inhibitors in diabetic chronic kidney disease: A systematic review and meta-analysis

More on SGLT2 inhibitors

• SGLT2 inhibitors raise genital but not urinary infection risk

  Clinical Pharmacology and Therapeutics · 4 Oct 2026

• SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs

  Diabetes & Vascular Disease Research · 4 Oct 2026

• Genetically proxied GIP pathway links to lower fracture risk

  Diabetes, Obesity & Metabolism · 4 Oct 2026

• Age and frailty shift optimal blood pressure for cognitive aging

  Journal of Alzheimer's Disease · 4 Oct 2026